Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.19.3.a.u2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Revenues [Abstract]        
Net sales $ 294,741 $ 350,175 $ 967,380 $ 1,027,024
Operating costs and expenses:        
Cost of sales 201,560 226,425 638,901 694,888
Selling, general and administrative expenses 50,031 48,271 147,243 149,071
Research and development 12,624 11,357 37,073 33,040
Restructuring charges 802 1,718 5,930 1,622
(Gain) loss on write down and disposal of long-lived assets 1,076 788 2,095 1,611
Total operating costs and expenses 266,093 288,559 831,242 880,232
Operating income (loss) 28,648 61,616 136,138 146,792
Non-operating (income) expense        
Interest income (904) (572) (2,525) (1,325)
Interest expense 2,803 4,480 8,099 18,803
Gain (Loss) Related to Litigation Settlement 1,597 281 64,695 4,563
Other (income) expense, net 3,091 13,725 450 2,083
Income (loss) before income taxes and equity income (loss) from equity method investments 22,061 43,702 65,419 122,668
Income tax expense (benefit) 5,400 2,600 23,900 9,200
Income (loss) before equity income (loss) from equity method investments 16,661 41,102 41,519 113,468
Equity income (loss) from equity method investments (59) (296) 163 (301)
Net income (loss) $ 16,602 $ 40,806 $ 41,682 $ 113,167
Net income (loss) per basic share:        
Net income (loss) per basic share (in usd per share) $ 0.28 $ 0.70 $ 0.71 $ 1.96
Net income (loss) per diluted share (in usd per share) 0.28 0.69 0.70 1.91
Dividends declared per share $ 0.05 $ 0.00 $ 0.10 $ 0.00
Weighted-average shares outstanding:        
Basic (in shares) 58,646 58,010 58,509 57,717
Diluted (in shares) 59,529 59,111 59,328 59,116